Effect of Tactile/Kinaesthetic Massage Therapy on DXA Parameter of Preterm Infants
1 other identifier
interventional
60
1 country
2
Brief Summary
The effect of Tactile/Kinaesthetic massage therapy on weight gain and different components of growth, as assessed by anthropometric measurements and DXA scan, and correlate these components with serum IGF-1, leptin and adiponectin in preterm infants.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Sep 2014
Longer than P75 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2014
CompletedFirst Submitted
Initial submission to the registry
January 21, 2018
CompletedFirst Posted
Study publicly available on registry
January 26, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2018
CompletedJune 8, 2022
June 1, 2022
4.3 years
January 21, 2018
June 7, 2022
Conditions
Outcome Measures
Primary Outcomes (5)
Growth parameter (Weight)
Daily weight gain in grams and cumulative weight gain after 5 days of intervention
5 days
Growth parameter (Length)
Daily length gain in cm and cumulative length gain after 5 days of intervention
5 days
Growth parameter (Head circumference)
Daily head circumference gain in cm and cumulative head circumference gain after 5 days of intervention
5 days
Growth parameter (Mid-arm circumference)
Daily mid-arm circumference gain in cm and cumulative mid-arm circumference gain after 5 days of intervention
5 days
Growth parameter (Ponderal Index)
Daily changes in Ponderal Index and cumulative changes in Ponderal Index after 5 days of intervention
5 days
Secondary Outcomes (4)
Dual X-ray absorptiometry scan (DXA scan)
5 days
Insulin-like Growth Factor 1 (IGF-1)
5 days
Serum Leptin
5 days
Serum adiponectin
5 days
Study Arms (2)
Control
NO INTERVENTIONInfants in this group will receive ordinary supportive care and will not receive Massage Therapy
Massage group
ACTIVE COMPARATORInfants in this group will receive Massage Therapy Massage therapy was started at corrected gestational age of 35 weeks and continued for 5 consecutive days. The protocol of massage therapy was performed as been described by Tiffany Field (Field, Schanberg et al. 1986). Three consecutive, 15 minutes, sessions were performed daily after the noon feeding. Each treatment session was divided into 5 minutes of tactile stimulation, followed by 5 minutes of kinaesthetic stimulation, and then another 5 minutes of tactile stimulation (Field, Diego et al. 2006). During massage therapy, infant's behavioural reaction was observed for signs of distress (e.g., yawning, finger splaying, crying).
Interventions
Massage therapy was started at corrected gestational age of 35 weeks and continued for 5 consecutive days. The protocol of massage therapy was performed as been described by Tiffany Field (Field, Schanberg et al. 1986). Three consecutive, 15 minutes, sessions were performed daily after the noon feeding. Each treatment session was divided into 5 minutes of tactile stimulation, followed by 5 minutes of kinaesthetic stimulation, and then another 5 minutes of tactile stimulation (Field, Diego et al. 2006).
Eligibility Criteria
You may qualify if:
- Medically stable premature infants with gestational age at 28 to 37 weeks' admitted to the "grower" (step-down) nursery. Stability is defined as lack of need for supplemental oxygen, apneas and bradycardias, systemic antimicrobial therapy for infection, or a central line. On at least 100 ml/kg/d of feed (oral or tube feed) preterm formula. informed consent will be obtained from parents before enrollment in the study.
You may not qualify if:
- History of necrotizing enterocolitis, receipt of postnatal steroids, active infection, congenital malformations, chromosomal abnormality, intracranial hemorrhage more than (\>) grade 2, inborn errors of metabolism, meningitis or encephalopathy, need for surgery.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Mansoura university children hospital
Al Mansurah, El Dakahlya, 35111, Egypt
Unknown Facility
Al Mansurah, Egypt
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
January 21, 2018
First Posted
January 26, 2018
Study Start
September 1, 2014
Primary Completion
December 1, 2018
Study Completion
December 1, 2018
Last Updated
June 8, 2022
Record last verified: 2022-06